The major histocompatibility complex class I (MHC-I) antigen presentation pathway is central to the adaptive immune response. In this process, intracellular proteins are degraded primarily by the ...

When most veterinarians hear the term "stem cell therapy," their minds often go to autologous procedures – tissue harvested ...

Immutep is continuing the AIPAC-003 trial, which enrolled 71 metastatic hormone receptor positive (HR+), HER2-negative/low or ...

A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating autophagy and MHC-I expression. The research, conducted by scientists from ...

Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical ...

During Summer League, Milwaukee Bucks general manager Jon Horst sat down with reporter Eric Nehm of The Athletic to disucss what the team has done so far and what further moves they’ll make ...

Melbourne scientists are teasing out how the "Hippo pathway" works at the molecular level, improving understanding of how it ...

A mutant DJ-1 gene causes recessive Parkinson's disease, but the molecular mechanism of this process has not been well ...

Myhlth Chck Share Chat. Chat About MHC Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not ...

Large studies are needed to see if targeted therapies work in the different types of IIM. As IIM is rare, this would best be done by many centres working together internationally.